Diabetes technology

Development of a three-dimensional scoring model for the assessment of continuous glucose monitoring data in type 1 diabetes

BMJ Open Diabetes Res CarePublished Retrospective cohort study

Authors' conclusion

Our scoring model captures the complexity of CGM data and can identify both the most alarming dimension of glycemia and the individuals in most urgent need of assistance. This could become a valuable tool for population management at diabetes clinics to enable healthcare providers to stratify care to the patients in greatest need of clinical attention.

Study context

Population
Individuals with T1D with continuous glucose monitoring (CGM) data 2017–2020 in electronic medical records82,114 days
Participants
613 individuals
Exposure
Scoring model vs clinical expert board (CEB)
Outcome
Identification of time periods with 'true' target fulfillment (score ≥80 cut-off)
Methodological detailsmodel development
  • Model development

Main finding

As reported in the abstract

Accuracy of score ≥80 cut-off for 'true' target fulfillment

93.4%

Specificity of score ≥80 cut-off for 'true' target fulfillment

97.1%

Accuracy of scoring model vs CEB for identifying the most alarming CGM curves (overall)

86.5%

Observational data: associations, not effects.

Further findings

Accuracy vs clinical expert board (CEB) in identifying most alarming CGM curves

Overall accuracy vs CEB
86.5%

Original publication

Development of a three-dimensional scoring model for the assessment of continuous glucose monitoring data in type 1 diabetes. BMJ Open Diabetes Res Care. Published 5 September 2024. doi:10.1136/bmjdrc-2024-004350

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.